Amar Kishan

Amar Kishan

University of California, Los Angeles

H-index: 35

North America-United States

About Amar Kishan

Amar Kishan, With an exceptional h-index of 35 and a recent h-index of 32 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-Assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol …

Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer

MRI-Guided Radiation Therapy for Prostate Cancer: Less Is More When Technology and Evidence Intersect

Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial

Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients …

Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer

Stereotactic Intensity Modulated Radiotherapy after Radical Prostatectomy (SCIMITAR): Two Year Quality of Life and Toxicity Outcomes of a Multicenter Phase II Trial

MOLECULAR CORRELATES WITH PSMA EXPRESSION IN PRIMARY PROSTATE CANCER

Amar Kishan Information

University

Position

___

Citations(all)

6476

Citations(since 2020)

5758

Cited By

2349

hIndex(all)

35

hIndex(since 2020)

32

i10Index(all)

114

i10Index(since 2020)

102

Email

University Profile Page

Google Scholar

Amar Kishan Skills & Research Interests

Oncology

Top articles of Amar Kishan

Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-Assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol …

European urology

2024/3/23

Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

MRI-Guided Radiation Therapy for Prostate Cancer: Less Is More When Technology and Evidence Intersect

2024/3/21

Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial

European Urology

2024/3/16

Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients …

International Journal of Radiation Oncology* Biology* Physics

2024/3/15

Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer

2024/2/1

Stereotactic Intensity Modulated Radiotherapy after Radical Prostatectomy (SCIMITAR): Two Year Quality of Life and Toxicity Outcomes of a Multicenter Phase II Trial

Cureus Journal of Medical Science

2024/3/6

MOLECULAR CORRELATES WITH PSMA EXPRESSION IN PRIMARY PROSTATE CANCER

Urologic Oncology: Seminars and Original Investigations

2024/3/1

Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study

European Journal of Cancer

2024/3/1

Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases

Practical Radiation Oncology

2024/3/1

The Potential Contribution of Radiopharmaceutical Therapies in Managing Oligometastatic Disease

Journal of Nuclear Medicine

2024/2/15

(016) Sexual Health Toxicity Following MRI-Guided versus CT-guided Prostate SBRT

The Journal of Sexual Medicine

2024/2

Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer.

2024/2/1

Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.

2024/2/1

Differential treatment effect on overall survival (OS) based on early prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer (mHSPC): A …

2024/2/1

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective …

European Urology Open Science

2022/10/1

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

2024/12

Amar Kishan
Amar Kishan

H-Index: 21

Impact of PSMA PET on Prostate Cancer Management

2024/1/25

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate-and High-Risk Prostate Cancer (PSMA-dRT Trial)

Journal of Nuclear Medicine

2024/4/25

The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning

2024/1/24

See List of Professors in Amar Kishan University(University of California, Los Angeles)